We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

130 hedge funds and large institutions have $648M invested in Arena Pharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 47 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

43% more call options, than puts

Call options by funds: $9.68M | Put options by funds: $6.75M

7% more funds holding

Funds holding: 122130 (+8)

6% more capital invested

Capital invested by funds: $611M → $648M (+$37.4M)

26% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 47

Holders
130
Holders Change
+8
Holders Change %
+6.56%
% of All Funds
3.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
35
Reduced
47
Closed
12
Calls
$9.68M
Puts
$6.75M
Net Calls
+$2.92M
Net Calls Change
+$3.71M
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$2.09M
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$2.05M +$87 +2 +0%
CCMH
28
Cornerstone Capital Management Holdings
New York
$1.88M +$1.74M +40,160 +10,568%
TA
29
Teachers Advisors
New York
$1.63M -$2.47M -56,990 -62%
USAA
30
United Services Automobile Association
Texas
$1.62M
Goldman Sachs
31
Goldman Sachs
New York
$1.57M +$380K +8,759 +35%
Allianz Asset Management
32
Allianz Asset Management
Germany
$1.5M -$617K -14,213 -31%
QI
33
QS Investors
New York
$1.44M
Ameriprise
34
Ameriprise
Minnesota
$1.34M +$1.25M +28,830 New
Swiss National Bank
35
Swiss National Bank
Switzerland
$1.26M +$33.8K +780 +3%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$1.18M +$1.1M +25,357 New
AA
37
ALPS Advisors
Colorado
$1.11M +$515K +11,874 +98%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$1.09M -$3.87M -89,312 -79%
CC
39
Callan Capital
California
$1.08M -$130K -3,000 -11%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$1.06M -$95K -2,190 -9%
ProShare Advisors
41
ProShare Advisors
Maryland
$1.04M -$74.7K -1,723 -7%
BA
42
BlackRock Advisors
Delaware
$972K +$248K +5,717 +38%
Deutsche Bank
43
Deutsche Bank
Germany
$958K +$342K +7,877 +61%
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$924K
DCM
45
DAFNA Capital Management
California
$877K +$820K +18,900 New
Millennium Management
46
Millennium Management
New York
$824K -$7.12M -164,155 -90%
Cambridge Investment Research Advisors
47
Cambridge Investment Research Advisors
Iowa
$815K -$421K -9,700 -36%
BG
48
BlackRock Group
United Kingdom
$793K +$59.7K +1,377 +9%
Bank of America
49
Bank of America
North Carolina
$793K +$675K +15,562 +1,018%
NFA
50
Nationwide Fund Advisors
Ohio
$728K -$86.1K -1,985 -11%

ARNA Hedge Fund Activity: Q2 2015 in Review

130 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2015, worth a combined $648M — up 6.1% from $611M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ARNA positions and 12 closed out — a net gain of 8 holders — while 35 added to existing stakes and 47 trimmed.

The largest buyer was State Street, adding an estimated $7.64M. The largest seller was Deerfield Management, cutting an estimated $9.74M.

  • 130 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2015, up from 122 in Q1 2015.
  • Funds reported $648M of Arena Pharmaceuticals Inc stock for Q2 2015, up 6.1% quarter-over-quarter.
  • 20 funds opened new Arena Pharmaceuticals Inc positions in Q2 2015 and 12 closed out, a net change of +8 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2015 was State Street, an estimated $7.64M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2015 was Deerfield Management, an estimated $9.74M sold.

Based on aggregated 13F filings for Q2 2015.